InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,324.00
(
0.38%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
74.66
(
0.05%
)
Bitcoin
61,395.16
(
1.27%
)
Post# of 253268
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

puravida

Send PM Follow Ignore
Followers 36
Posts 1736
Boards Moderated 0
Alias Born 05/13/2011

puravida

Re: None

Monday, 01/13/2020 8:27:56 AM

Monday, January 13, 2020 8:27:56 AM

Post# of 253268
MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab

MorphoSys and Incyte to co-commercialize tafasitamab in the U.S.

- Incyte has exclusive commercialization rights outside of the U.S.

- MorphoSys and Incyte to host joint conference call on January 13, 2020 at 7:00am PST / 4:00pm CET



https://www.morphosys.com/media-investors/media-center/morphosys-and-incyte-sign-global-collaboration-and-license-agreement
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up